Medium-Dose Riboflavin as a Prophylactic Agent in Children With Migraine: A Preliminary Placebo-Controlled, Randomised, Double-Blind, Cross-Over Trial
Cephalalgia - United States
doi 10.1177/0333102410365106
Full Text
Open PDFAbstract
Available in full text
Date
March 26, 2010
Authors
Publisher
SAGE Publications